Trial Details
Not RecruitingBasic Information
| Clinical ID | c2931 |
|---|---|
| Identifier | JPRN-UMIN000022575 |
| Trial Title | Clinical efficacy and safety of oral Qing-Dai in patients with inflammatory bowel disease - Clinical efficacy and safety of oral Qing-Dai in patients with inflammatory bowel disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | Yes |
|---|---|
| Conditions | Ulcerative colitis,Crohn disease |
| Interventions | Patients take oral Qing-Dai in capsule form twice a day(daily dose,2g)for 4 weeks.If patients achieve clinical remission or show clinical response,they will be allowed to continue taking these drugs for 52 weeks. |
Participant Information
| Sponsor | Kyushu University |
|---|---|
| City | - |
| Country/Region | Japan |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | 2019-03-29 |